Cholecystitis resident survival guide: Difference between revisions
No edit summary |
No edit summary |
||
Line 72: | Line 72: | ||
{{familytree | | |!| | | | | F01 | | | | F02 | |F01=HIDA scan|F02=[[Abdominal pain resident survival guide|Consider evaluation for alternate diagnosis of abdominal pain]]}} | {{familytree | | |!| | | | | F01 | | | | F02 | |F01=HIDA scan|F02=[[Abdominal pain resident survival guide|Consider evaluation for alternate diagnosis of abdominal pain]]}} | ||
{{familytree | | |!| | | |,|-|^|-|.| | | | | | |}} | {{familytree | | |!| | | |,|-|^|-|.| | | | | | |}} | ||
{{familytree | | G01 |-| G02 | | G03 | | | | | |G01=<div style="float: left; text-align: left; line-height: 150% ">'''[[Cholecystitis overview#Diagnostic Criteria|Diagnostic criteria]]''':<ref name="Takada-2007">{{Cite journal | last1 = Takada | first1 = T. | last2 = Kawarada | first2 = Y. | last3 = Nimura | first3 = Y. | last4 = Yoshida | first4 = M. | last5 = Mayumi | first5 = T. | last6 = Sekimoto | first6 = M. | last7 = Miura | first7 = F. | last8 = Wada | first8 = K. | last9 = Hirota | first9 = M. | title = Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 1-10 | month = | year = 2007 | doi = 10.1007/s00534-006-1150-0 | PMID = 17252291 }}</ref><ref name="Hirota-2007">{{Cite journal | last1 = Hirota | first1 = M. | last2 = Takada | first2 = T. | last3 = Kawarada | first3 = Y. | last4 = Nimura | first4 = Y. | last5 = Miura | first5 = F. | last6 = Hirata | first6 = K. | last7 = Mayumi | first7 = T. | last8 = Yoshida | first8 = M. | last9 = Strasberg | first9 = S. | title = Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 78-82 | month = | year = 2007 | doi = 10.1007/s00534-006-1159-4 | PMID = 17252300 }}</ref><br>❑ Local symptoms & signs | {{familytree | | G01 |-| G02 | | G03 | | | | | |G01=<div style="float: left; text-align: left; line-height: 150% ">'''[[Cholecystitis overview#Diagnostic Criteria|Diagnostic criteria]]''':<ref name="Takada-2007">{{Cite journal | last1 = Takada | first1 = T. | last2 = Kawarada | first2 = Y. | last3 = Nimura | first3 = Y. | last4 = Yoshida | first4 = M. | last5 = Mayumi | first5 = T. | last6 = Sekimoto | first6 = M. | last7 = Miura | first7 = F. | last8 = Wada | first8 = K. | last9 = Hirota | first9 = M. | title = Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 1-10 | month = | year = 2007 | doi = 10.1007/s00534-006-1150-0 | PMID = 17252291 }}</ref><ref name="Hirota-2007">{{Cite journal | last1 = Hirota | first1 = M. | last2 = Takada | first2 = T. | last3 = Kawarada | first3 = Y. | last4 = Nimura | first4 = Y. | last5 = Miura | first5 = F. | last6 = Hirata | first6 = K. | last7 = Mayumi | first7 = T. | last8 = Yoshida | first8 = M. | last9 = Strasberg | first9 = S. | title = Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 78-82 | month = | year = 2007 | doi = 10.1007/s00534-006-1159-4 | PMID = 17252300 }}</ref><br>❑ Local symptoms & signs | ||
:❑ [[Murphy’s sign]] | :❑ [[Murphy’s sign]] | ||
:❑ Pain or tenderness in RUQ | :❑ Pain or tenderness in RUQ | ||
:❑ Mass in RUQ | :❑ Mass in RUQ<br> | ||
❑ Systemic signs | |||
:❑ Fever | :❑ Fever | ||
:❑ Leukocytosis | :❑ Leukocytosis | ||
:❑ Elevated CRP | :❑ Elevated CRP<br> | ||
❑ Imaging findings | |||
:❑ [[Cholecystitis ultrasound#Calculous Cholecystitis|TAUSG]] | :❑ [[Cholecystitis ultrasound#Calculous Cholecystitis|TAUSG]] | ||
:❑ [[Cholecystitis other diagnostic studies#Calculous Cholecystitis|HIDA scan]] | :❑ [[Cholecystitis other diagnostic studies#Calculous Cholecystitis|HIDA scan]]</div>|G02=GB opacity not visualized|G03=GB opacity visualized}} | ||
{{familytree | | |!| | | | | | | |!| | | | | | | |}} | {{familytree | | |!| | | | | | | |!| | | | | | | |}} | ||
{{familytree | | |)|-|-| H01 | | H02 | | | | | | |H01=W/ significantly elevated total bilirubin, alkaline phosphatase, ALT, AST &/or GGT|H02=CT abdomen}} | {{familytree | | |)|-|-| H01 | | H02 | | | | | | |H01=W/ significantly elevated total bilirubin, alkaline phosphatase, ALT, AST &/or GGT|H02=CT abdomen}} | ||
{{familytree | | |!| | | |!| | | |!| | | | | | | |}} | {{familytree | | |!| | | |!| | | |!| | | | | | | |}} | ||
{{familytree | | I01 | | I02 | | I03 | | | | | | |I01='''Acute calculous cholecystitis'''<br>w/ or w/o complications|I02=Consider evaluation for alternate diagnosis like [[choledocholithiasis]] & [[cholangitis]]|I03=<div style="float: left; text-align: left; line-height: 150% ">'''Diagnostic criteria:'''<ref name="Huffman-2010">{{Cite journal | last1 = Huffman | first1 = JL. | last2 = Schenker | first2 = S. | title = Acute acalculous cholecystitis: a review. | journal = Clin Gastroenterol Hepatol | volume = 8 | issue = 1 | pages = 15-22 | month = Jan | year = 2010 | doi = 10.1016/j.cgh.2009.08.034 | PMID = 19747982 }}</ref><BR>❑ Acute abdominal pain<BR>❑ Fever<BR>❑ Leukocytosis<BR>❑ Abnormal liver function tets<BR>❑ Imaging based criteria | {{familytree | | I01 | | I02 | | I03 | | | | | | |I01='''Acute calculous cholecystitis'''<br>w/ or w/o complications|I02=Consider evaluation for alternate diagnosis like [[choledocholithiasis]] & [[cholangitis]]|I03=<div style="float: left; text-align: left; line-height: 150% ">'''Diagnostic criteria:'''<ref name="Huffman-2010">{{Cite journal | last1 = Huffman | first1 = JL. | last2 = Schenker | first2 = S. | title = Acute acalculous cholecystitis: a review. | journal = Clin Gastroenterol Hepatol | volume = 8 | issue = 1 | pages = 15-22 | month = Jan | year = 2010 | doi = 10.1016/j.cgh.2009.08.034 | PMID = 19747982 }}</ref><BR>❑ Acute abdominal pain<BR>❑ Fever<BR>❑ Leukocytosis<BR>❑ Abnormal liver function tets<BR>❑ Imaging based criteria | ||
:❑ [[Cholecystitis ultrasound#Imaging Criteria for Acalculous Cholecystitis|TAUSG based]] | :❑ [[Cholecystitis ultrasound#Imaging Criteria for Acalculous Cholecystitis|TAUSG based]] | ||
:❑ [[Cholecystitis other diagnostic studies#Imaging Criteria for Acalculous Cholecystitis|HIDA scan based]] | :❑ [[Cholecystitis other diagnostic studies#Imaging Criteria for Acalculous Cholecystitis|HIDA scan based]] | ||
:❑ [[Cholecystitis CT#Imaging Criteria for Acalculous Cholecystitis|CT based criteria]] | :❑ [[Cholecystitis CT#Imaging Criteria for Acalculous Cholecystitis|CT based criteria]]</div>}} | ||
{{familytree | | | | | | | | | | |!| | | | | | | |}} | {{familytree | | | | | | | | | | |!| | | | | | | |}} | ||
{{familytree | | | | | | | | | | J01 | | | | | | |J01=Suspect '''acute acalculous cholecystitis'''}} | {{familytree | | | | | | | | | | J01 | | | | | | |J01=Suspect '''acute acalculous cholecystitis'''}} | ||
Line 120: | Line 122: | ||
{{familytree | | B01 | | | | | | | | | | | | B02 | | | | |B01='''Acute calculous cholecystitis'''<br>w/ or w/o complications|B02='''Acute acalculous cholecystitis'''}} | {{familytree | | B01 | | | | | | | | | | | | B02 | | | | |B01='''Acute calculous cholecystitis'''<br>w/ or w/o complications|B02='''Acute acalculous cholecystitis'''}} | ||
{{familytree | | |!| | | | | | | | | | | | | |!| | | | | |}} | {{familytree | | |!| | | | | | | | | | | | | |!| | | | | |}} | ||
{{familytree | | C01 | | | | | | | | | | | | C02 | | | ||C01=<div style="float: left; text-align: left; line-height: 150% "><BR>❑ Hospital admission<BR>❑ NPO<br>❑ IVF & correct electrolyte abnormalities<br>❑ Empiric IV antibiotics<ref name="Solomkin-2003">{{Cite journal | last1 = Solomkin | first1 = JS. | last2 = Mazuski | first2 = JE. | last3 = Baron | first3 = EJ. | last4 = Sawyer | first4 = RG. | last5 = Nathens | first5 = AB. | last6 = DiPiro | first6 = JT. | last7 = Buchman | first7 = T. | last8 = Dellinger | first8 = EP. | last9 = Jernigan | first9 = J. | title = Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. | journal = Clin Infect Dis | volume = 37 | issue = 8 | pages = 997-1005 | month = Oct | year = 2003 | doi = 10.1086/378702 | PMID = 14523762 }}</ref | {{familytree | | C01 | | | | | | | | | | | | C02 | | | ||C01=<div style="float: left; text-align: left; line-height: 150% "><BR>❑ Hospital admission<BR>❑ NPO<br>❑ IVF & correct electrolyte abnormalities<br>❑ Empiric IV antibiotics<ref name="Solomkin-2003">{{Cite journal | last1 = Solomkin | first1 = JS. | last2 = Mazuski | first2 = JE. | last3 = Baron | first3 = EJ. | last4 = Sawyer | first4 = RG. | last5 = Nathens | first5 = AB. | last6 = DiPiro | first6 = JT. | last7 = Buchman | first7 = T. | last8 = Dellinger | first8 = EP. | last9 = Jernigan | first9 = J. | title = Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. | journal = Clin Infect Dis | volume = 37 | issue = 8 | pages = 997-1005 | month = Oct | year = 2003 | doi = 10.1086/378702 | PMID = 14523762 }}</ref> | ||
:❑ [[Ceftriaxone]] 1 g IV every 24 hours/2 g IV every 12 hours for CNS infections<br>'''+'''<br> [[Metronidazole]] 500 mg IV every 8 hours | :❑ [[Ceftriaxone]] 1 g IV every 24 hours/2 g IV every 12 hours for CNS infections<br>'''+'''<br> [[Metronidazole]] 500 mg IV every 8 hours | ||
'''or''' | '''or''' | ||
:❑ [[Ciprofloxacin]] 400 mg IV every 12 hours<br> '''or'''<br> [[Levofloxacin]] 500 or 750 mg IV once daily<br> '''+'''<br> Metronidazole 500 mg IV every 8 hours | :❑ [[Ciprofloxacin]] 400 mg IV every 12 hours<br> '''or'''<br> [[Levofloxacin]] 500 or 750 mg IV once daily<br> '''+'''<br> Metronidazole 500 mg IV every 8 hours<br>❑ Acute pain management | ||
:❑ [[Ketorolac]] 30-60 mg IM/IV single dose | :❑ [[Ketorolac]] 30-60 mg IM/IV single dose | ||
'''or''' | '''or''' | ||
:❑ [[Opioids]] until cholecystectomy if ketorolac is contraindicated/pain not improving | :❑ [[Opioids]] until cholecystectomy if ketorolac is contraindicated/pain not improving<br> | ||
❑ [[Cholecystitis overview#Severity Grading|Assess severity]]<ref name="Hirota-2007">{{Cite journal | last1 = Hirota | first1 = M. | last2 = Takada | first2 = T. | last3 = Kawarada | first3 = Y. | last4 = Nimura | first4 = Y. | last5 = Miura | first5 = F. | last6 = Hirata | first6 = K. | last7 = Mayumi | first7 = T. | last8 = Yoshida | first8 = M. | last9 = Strasberg | first9 = S. | title = Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 78-82 | month = | year = 2007 | doi = 10.1007/s00534-006-1159-4 | PMID = 17252300 }}</ref></div>|C02=Immediate biliary drainage}} | ❑ [[Cholecystitis overview#Severity Grading|Assess severity]]<ref name="Hirota-2007">{{Cite journal | last1 = Hirota | first1 = M. | last2 = Takada | first2 = T. | last3 = Kawarada | first3 = Y. | last4 = Nimura | first4 = Y. | last5 = Miura | first5 = F. | last6 = Hirata | first6 = K. | last7 = Mayumi | first7 = T. | last8 = Yoshida | first8 = M. | last9 = Strasberg | first9 = S. | title = Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. | journal = J Hepatobiliary Pancreat Surg | volume = 14 | issue = 1 | pages = 78-82 | month = | year = 2007 | doi = 10.1007/s00534-006-1159-4 | PMID = 17252300 }}</ref></div>|C02=Immediate biliary drainage}} | ||
{{familytree | | |)|-|-|-|v|-|-|-|.| | | |,|-|^|-|.| | |}} | {{familytree | | |)|-|-|-|v|-|-|-|.| | | |,|-|^|-|.| | |}} |
Revision as of 21:42, 10 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]
Definitions
Cholecystitis is the inflammation of the gallbladder.
Shown below is a table summarizing the different key terms used to refer to cholecystitis.
Terms | Definitions |
---|---|
Acute cholecystitis | Acute cholecystitis is an acute inflammatory disease of the gallbladder, most often attributable to gallstones.[1][2] |
Acute calculous cholecystitis | Acute calculous cholecystitis is an acute inflammatory disease of the gallbladder in the presence of cholelithiasis.[1] The Tokyo guidelines is used in the diagnosis of acute calculous cholecystitis.[3][4] |
Acute acalculous cholecystitis | Acute acalculous cholecystitis is an acute necroinflammatory disease of the gallbladder in the absence of cholelithiasis and has a multifactorial pathogenesis.[5] Data from multiple studies is used for suspecting the diagnosis of acute acalculous cholecystitis.[5] |
Chronic cholecystitis | Chronic cholecystitis is a chronic inflammatory disease of the gallbladder with histological evidence of chronic inflammation like large range of related inflammatory epithelial changes including mononuclear infiltrate, fibrosis, thickening of muscular layer, dysplasia, hyperplasia and metaplasia.[6] |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Management
Shown below are algorithms depicting the diagnostic and treatment approach of acute and chronic cholecystitis according to the Society for Surgery of the Alimentary Tract (SSAT),[8] the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES),[9] the Tokyo guidelines for management of cholecystitis,[10] and review of data from multiple studies on acalculous cholecystitis.[5]
Diagnostic Approach
Acute Cholecystitis
Characterize the symptoms: ❑ Acute RUQ or epigastric pain
❑ Acute vague abdominal pain
| |||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ Febrile ❑ Jaundice ❑ Dehydrated ❑ Tachycardia ❑ RUQ mass ❑ Abdominal guarding ❑ Murphy's sign ❑ Abdominal crepitations ❑ Abdominal tenderness ❑ Reduced bowel sounds ❑ Increased bowel sounds ❑ Abdominal distension ❑ Signs of sepsis | |||||||||||||||||||||||||||||||||||||
Probable diagnosis: ❑ Acute calculous cholecystitis ❑ Acute acalculous cholecystitis Differential diagnosis ❑ Acute hepatitis ❑ Acute pancreatitis ❑ Appendicitis ❑ Biliary colic ❑ Cardiac ischemia ❑ Diseases of the right kidney ❑ Fitz-Hugh-Curtis syndrome ❑ Functional gallbladder disorder ❑ Irritable bowel disease ❑ Nonulcer dyspepsia ❑ Peptic ulcer disease ❑ Perforated viscus ❑ Right-sided pneumonia ❑ Sphincter of Oddi dysfunction ❑ Subhepatic or intraabdominal abscess | |||||||||||||||||||||||||||||||||||||
Order laboratory tests: ❑ CBC ❑ BMP ❑ CRP ❑ Total bilirubin ❑ Direct bilirubin ❑ Albumin ❑ AST ❑ ALT ❑ Alkaline phosphatase ❑ GGT ❑ Amylase ❑ Lipase Order urgent transabdominal USG (TAUSG) | |||||||||||||||||||||||||||||||||||||
GBS w/ GB edema | GBS w/o GB edema/GB edema w/o GBS | No GBS/GB edema | |||||||||||||||||||||||||||||||||||
HIDA scan | Consider evaluation for alternate diagnosis of abdominal pain | ||||||||||||||||||||||||||||||||||||
Diagnostic criteria:[3][4] ❑ Local symptoms & signs
❑ Systemic signs
❑ Imaging findings | GB opacity not visualized | GB opacity visualized | |||||||||||||||||||||||||||||||||||
W/ significantly elevated total bilirubin, alkaline phosphatase, ALT, AST &/or GGT | CT abdomen | ||||||||||||||||||||||||||||||||||||
Acute calculous cholecystitis w/ or w/o complications | Consider evaluation for alternate diagnosis like choledocholithiasis & cholangitis | Diagnostic criteria:[5] ❑ Acute abdominal pain ❑ Fever ❑ Leukocytosis ❑ Abnormal liver function tets ❑ Imaging based criteria | |||||||||||||||||||||||||||||||||||
Suspect acute acalculous cholecystitis | |||||||||||||||||||||||||||||||||||||
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMP: Basic metabolic profile; CBC: Complete blood count; CRP: C-reactive protein; CT: Computed tomography; GB: Gallbladder; GBS: Gallbladder stone; GGT: Gamma-glutamyl transpeptidase; HIDA scan: Hepatobiliary iminodiacetic acid scan; RUQ: Right upper quadrant; Sx: Symptom; W/: With; W/O: Without
Chronic Cholecystitis
Characterize the symptoms: ❑ Recurrent biliary type abdominal pain w/ or w/o fever ❑ Recurrent abdominal bloating ❑ Unstable stool with constipation/diarrhea ❑ Weight loss | |||||||||||||||||||||||||||||||||||
Probable diagnosis: ❑ Chronic cholecystitis Differential diagnosis ❑ Biliary colic ❑ Cholangiocarcinoma ❑ Choledocholithiasis ❑ Cholelithiasis ❑ Gallbladder cancer ❑ Gallbladder mucocele ❑ Peptic ulcer disease | |||||||||||||||||||||||||||||||||||
Order laboratory tests: ❑ CBC ❑ BMP ❑ CRP ❑ Total bilirubin ❑ Direct bilirubin ❑ Albumin ❑ AST ❑ ALT ❑ Alkaline phosphatase ❑ GGT ❑ Amylase ❑ Lipase Order imaging studies: ❑ TAUSG ❑ CT abdomen ❑ HIDA scan ❑ Cholecystokinin stimulated HIDA scan | |||||||||||||||||||||||||||||||||||
Diagnostic criteria: ❑ Chronic biliary Sx ❑ Absence of other pain sources during CT ❑ Stone-free TAUSG ❑ Delayed GB isotope accumulation, irregular GB filling, or photopenic areas and septations during HIDA cholescintigraphy ❑ Low EF (<35%) in cholecystokinin stimulated HIDA scan | |||||||||||||||||||||||||||||||||||
Suspect chronic cholecystitis | |||||||||||||||||||||||||||||||||||
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMP: Basic metabolic profile; CBC: Complete blood count; CRP: C-reactive protein; CT: Computed tomography; EF: Ejection fraction; GB: Gallbladder; GGT: Gamma-glutamyl transpeptidase; HIDA scan: Hepatobiliary iminodiacetic acid scan; Sx: Symptom; TAUSG: Transabdominal ultrasonography; W/: With; W/O: Without
Treatment Approach
Acute Cholecystitis
Acute cholecystitis | |||||||||||||||||||||||||||||||||||||||||||||
Acute calculous cholecystitis w/ or w/o complications | Acute acalculous cholecystitis | ||||||||||||||||||||||||||||||||||||||||||||
❑ Hospital admission ❑ NPO ❑ IVF & correct electrolyte abnormalities ❑ Empiric IV antibiotics[11]
or
or
| Immediate biliary drainage | ||||||||||||||||||||||||||||||||||||||||||||
Grade 1 (Mild) | Grade 2 (Moderate) | Grade 3 (Severe) | Patient improves | Patient does not improve | |||||||||||||||||||||||||||||||||||||||||
Cholecystectomy within 72 hours | W/o complications & non high risk surgical candidates: Immediate cholecystectomy + blood C&S ± bile C&S W/o complications & high risk surgical candidates: Immediate biliary drainage + blood C&S ± bile C&S W/ complications: Emergency cholecystectomy + blood C&S ± bile C&S ± appropriate surgeries for gallstone ileus & Mirizzi syndrome | Emergency biliary drainage + blood C&S ± bile C&S | Urgent cholecystectomy | Consider evaluation for alternate diagnosis of abdominal pain | |||||||||||||||||||||||||||||||||||||||||
Cholecystectomy after 3 months if GBS found during biliary drainage | |||||||||||||||||||||||||||||||||||||||||||||
CNS: Central nervous system; C&S: Culture & sensitivity; GBS: Gallbladder stone; IV: Intravenous; IVF: Intravenous fluids; NPO: Nil per oral; W/: With; W/O: Without
Chronic Cholecystitis
Chronic cholecystitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Uncomplicated chronic cholecystitis: Elective cholecystectomy | Complicated chronic cholecystitis: Appropriate management of complications ❑ Acute on chronic cholecystitis ❑ Gallbladder carcinoma ❑ Gallstone ileus | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Antibiotics should be administered if infection is suspected on the basis of laboratory and clinical findings (>12,500 white cells/mm 3 or temperature >38.5°C) and radiographic findings (e.g., air in the gallbladder or gallbladder wall) as per the Infectious Diseases Society of America recommendation.[11]
- Prophylactic antibiotics before surgery
- Should be administered in highrisk patients (age >60 years, presence of diabetes, acute colic within 30 days of operation, jaundice, acute cholecystitis, or cholangitis) (Level I, Grade B).
- Should be limited to a single preoperative dose given within 1 hour of skin incision (Level II, Grade A).
- Early laparoscopic cholecystectomy is the preferred approach and should be done in patients with acute cholecystitis (Level II, Grade B).
- Radiographically guided percutaneous cholecystostomy is the effective method of biliary drainage and should be done in critically ill patients with acute cholecystitis, until the patient recovers sufficiently to undergo cholecystectomy (Level II, Grade B).
- Time to discharge after surgery for patients with acute cholecystitis should be determined on an individual basis (Level III, Grade A).
Dont's
- Antibiotics are not required in low-risk patients undergoing laparoscopic cholecystectomy (Level I, Grade A).
- Drains are not required after elective laparoscopic cholecystectomy, and their use may increase complication rates. (Level I, Grade A).
References
- ↑ 1.0 1.1 Strasberg, SM. (2008). "Clinical practice. Acute calculous cholecystitis". N Engl J Med. 358 (26): 2804–11. doi:10.1056/NEJMcp0800929. PMID 18579815. Unknown parameter
|month=
ignored (help) - ↑ Reiss, R.; Deutsch, AA. (1993). "State of the art in the diagnosis and management of acute cholecystitis". Dig Dis. 11 (1): 55–64. PMID 8443956.
- ↑ 3.0 3.1 Takada, T.; Kawarada, Y.; Nimura, Y.; Yoshida, M.; Mayumi, T.; Sekimoto, M.; Miura, F.; Wada, K.; Hirota, M. (2007). "Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis". J Hepatobiliary Pancreat Surg. 14 (1): 1–10. doi:10.1007/s00534-006-1150-0. PMID 17252291.
- ↑ 4.0 4.1 4.2 Hirota, M.; Takada, T.; Kawarada, Y.; Nimura, Y.; Miura, F.; Hirata, K.; Mayumi, T.; Yoshida, M.; Strasberg, S. (2007). "Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 78–82. doi:10.1007/s00534-006-1159-4. PMID 17252300.
- ↑ 5.0 5.1 5.2 5.3 Huffman, JL.; Schenker, S. (2010). "Acute acalculous cholecystitis: a review". Clin Gastroenterol Hepatol. 8 (1): 15–22. doi:10.1016/j.cgh.2009.08.034. PMID 19747982. Unknown parameter
|month=
ignored (help) - ↑ Zhou, D.; Guan, WB.; Wang, JD.; Zhang, Y.; Gong, W.; Quan, ZW. (2013). "A comparative study of clinicopathological features between chronic cholecystitis patients with and without Helicobacter pylori infection in gallbladder mucosa". PLoS One. 8 (7): e70265. doi:10.1371/journal.pone.0070265. PMID 23936177.
- ↑ Kimura, Y.; Takada, T.; Kawarada, Y.; Nimura, Y.; Hirata, K.; Sekimoto, M.; Yoshida, M.; Mayumi, T.; Wada, K. (2007). "Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMID 17252293.
- ↑ Duncan, CB.; Riall, TS. (2012). "Evidence-based current surgical practice: calculous gallbladder disease". J Gastrointest Surg. 16 (11): 2011–25. doi:10.1007/s11605-012-2024-1. PMID 22986769. Unknown parameter
|month=
ignored (help) - ↑ Overby, DW.; Apelgren, KN.; Richardson, W.; Fanelli, R.; Overby, DW.; Apelgren, KN.; Beghoff, KR.; Curcillo, P.; Awad, Z. (2010). "SAGES guidelines for the clinical application of laparoscopic biliary tract surgery". Surg Endosc. 24 (10): 2368–86. doi:10.1007/s00464-010-1268-7. PMID 20706739. Unknown parameter
|month=
ignored (help) - ↑ Mayumi, T.; Someya, K.; Ootubo, H.; Takama, T.; Kido, T.; Kamezaki, F.; Yoshida, M.; Takada, T. (2013). "Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis". J UOEH. 35 (4): 249–57. PMID 24334691. Unknown parameter
|month=
ignored (help) - ↑ 11.0 11.1 Solomkin, JS.; Mazuski, JE.; Baron, EJ.; Sawyer, RG.; Nathens, AB.; DiPiro, JT.; Buchman, T.; Dellinger, EP.; Jernigan, J. (2003). "Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections". Clin Infect Dis. 37 (8): 997–1005. doi:10.1086/378702. PMID 14523762. Unknown parameter
|month=
ignored (help)